AbolerIS Pharma
Biotechnology company that will develop novel and unique therapeutic approaches to induce immune tolerance and preserves useful immune responses in inflammatory, autoimmune and degenerative diseases. Learn more
Launch date
Employees
Market cap
-
Enterprise valuation
$120—180m (Dealroom.co estimates Sep 2023.)
Company register number 879302800
Charleroi Hainaut Province (HQ), Nantes Pays de la Loire (founding location)
Authorizing premium user...